MedPath

Effect of heparin in the prevention of central vein catheter

Phase 3
Conditions
Central vein catheters occlution.
Complications of other internal prosthetic devices, implants and grafts
Registration Number
IRCT20190905044704N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
150
Inclusion Criteria

All ICU admitted patients who had 3 functional lumen catheter that insert less than 12 hours

Exclusion Criteria

Dialysis and phresis and pulmonary artery catheters and insertable ports
Age less than 18 y/o
Pregnancy
Heparin sensivity and HIT
Coagolation system disorder and thrombocytopenia
Therapeutic dose of anticoagolant
Packed cell or any blood products transfusion
TPN
If the active lines needed more than 3 time hepparizination were excluded

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Central vein catheter occlution. Timepoint: Central vein catheters was checked every 8 hours untill 14 days. Method of measurement: Aspiration and infusion.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath